Large Cap Biotech Analyst Fye holds a conference call President & CEO Kewalramani and EVP & COO Arbuckle on March 1 at 10 am hosted by JPMorgan.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VRTX:
- Vertex Pharmaceuticals CSO Altshuler sells 3,002 common shares
- Vertex Pharmaceuticals reports CHMP opinion for label extension of Kalydeco
- Crispr Therapeutics price target raised to $112 from $110 at Chardan
- A New Cause for Concern: Vertex Pharmaceuticals Inc. Adds a New Regulation Risk
- Vertex Pharmaceuticals initiated with an Outperform at Wolfe Research
